Clinical trials: CGM
type1diabetes, CGM
Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System
The study is to evaluate the accuracy and safety of a real-time CGM system among adult patients with type 1 diabetes with respect to reference venous plasma sample measurements.
- Conditions
- type1diabetes, CGM, T1D
- Trial name
- NCT07745244
- Testing
- GS3 CGM
- Where
- China
- Volunteers
- 36 people
- Sponsor
- SiBionics, Co, Ltd
Type 2 Diabetes, Kidney Disease
Efficacy of the Use of Real-time Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes and Stage 3 and 4 Chronic Kidney Disease.
Rationale: Glucose control in patients with kidney disease is challenging, as traditional metrics can be unreliable and there is a high risk of hypoglycemia (low blood sugar).
- Conditions
- Type 2 Diabetes, Kidney Disease, CGM, Time in Range
- Trial name
- NCT07668219
- Testing
- Real time continuos glucose monitoring, self blood glucose monitoring
- Where
- Colombia
- Volunteers
- 30 people
- Sponsor
- Hospital Universitario San Ignacio
Diabetes Mellitus Type 2, Infection
Automated Insulin Delivery Versus Daily Injections for Hospital Diabetes Care
Aim The investigators aim to investigate if automated insulin delivery systems (AID) improve in-hospital glycemic and clinical outcomes in patients with type 2 diabetes compared to standard-of-care with a pen-basal-bolus insulin…
- Conditions
- Diabetes Mellitus Type 2, Infection, CGM
- Trial name
- NCT07645079
- Testing
- automated insulin delivery system, GlucoTab, Control-arm
- Where
- 2 sites in Austria, Denmark
- Volunteers
- 92 people
- Sponsor
- Steno Diabetes Center Copenhagen
CGM, Intensive Care (ICU)
Evaluate the Performance of the Dexcom G7 Continuous Glucose Monitoring (CGM) System in Critically Ill Patients Undergoing Major Abdominal Surgery and Solid Organ Transplantation Which Require Blood Glucose Monitoring for Intensive Insulin Therapy.
Main objective: The goal is to to determine the accuracy of Dexcom G7 Continuous glucose monitor system in critically ill patients, undergoing major abdominal surgery and solid organ transplantation, in the intensive care unit.
- Conditions
- CGM, Intensive Care (ICU), Liver Transplant Surgery, Solid Organ Transplantation
- Trial name
- DREAM-ICU (NCT07611721)
- Testing
- Continuous glucose monitor
- Where
- Czechia
- Volunteers
- 62 people
- Sponsor
- Institute for Clinical and Experimental Medicine
Type 2 Diabetes Mellitus (T2DM), Continuous Glucose Monitoring
Transition to Hospital Discharge in Insulinized Patients With Type 2 Diabetes Mellitus
This clinical study explores whether adding technological tools during hospital discharge can help people with type 2 diabetes who are starting insulin therapy achieve better treatment adherence and blood glucose control once…
- Conditions
- Type 2 Diabetes Mellitus (T2DM), Continuous Glucose Monitoring, CGM, Transition to Discharge
- Trial name
- TRANHOSPIN (NCT07061301)
- Testing
- Usual Care group, Technological group
- Where
- Spain
- Volunteers
- 80 people
- Sponsor
- Instituto de Investigacion Sanitaria La Fe
Cgm, Gestational Diabetes
Real-time Continuous Glucose Monitoring for Reduced Adverse Complications and Events in Women With Gestational Diabetes (GRACE): a Multicentre International Randomized Controlled Trial
Real-time continuous glucose monitoring (CGM) systems provide users with information about current glucose levels and alert the patient before the upper or lower glucose threshold is reached or when glucose levels change rapidly.
- Conditions
- Cgm, Gestational Diabetes, Pregnancy Complications, Blood Glucose
- Trial name
- GRACE (NCT03981328)
- Testing
- Dexcom G6 Continuous Glucose Monitoring System, self-monitored blood glucose
- Where
- Austria
- Volunteers
- 375 people
- Sponsor
- Medical University of Vienna
Cardiovascular Diseases, Coronary Artery Disease
Using the Visualization for Lifestyle Change in Patients At Risk of Cardiovascular Diseases
In the framework of PhD research, the investigators will present a visualization of estimation of CVDs risk and the possibility of monitoring blood glucose levels in real-time.
- Conditions
- Cardiovascular Diseases, Coronary Artery Disease, Heart Diseases, Coronary Heart Disease
- Trial name
- NCT06226948
- Testing
- CGM, Visualization
- Where
- Slovenia
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- University Maribor
Efficacy of a 21-Day Wear Period for the Cascade CGM
Glucomen Day Cascade CGM System 21-Day Wear Study
Assessment of 21-day CGM wear period
- Trial name
- GLUCODAY21 (NCT05460260)
- Testing
- Cascade CGM
- Where
- 2 sites in Croatia, Slovenia
- Volunteers
- 10 people
- Sponsor
- WaveForm Technologies Inc.
SANZ®KINGWILL Combined With CGM Equipment in GDM Patients, GLUCERNA SR® Combined With CGM Equipment in GDM Patients
Nutrition Product Combine With Continuous Glucose Monitoring in Gestational Diabetes Mellitus Patients
A prospective, multicenter, randomized controlled trial including about 60 Gestational Diabetes Mellitus patients (GDM) in Beijing will be included to evaluate the effectiveness and safety of nutrition product (SANZ®KINGWILL) in…
- Trial name
- NCT04368741
- Testing
- SANZ®KINGWILL, GLUCERNA SR®
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Peking Union Medical College Hospital
Type 1 Diabetes Mellitus, MDI
Evaluation of Physician-based Decision Support
The goal of this study is to assess the impact of physician-driven insulin setting changes in type 1 patients using multiple daily injection insulin therapy with exercise.
- Conditions
- Type 1 Diabetes Mellitus, MDI, CGM, Exercise
- Trial name
- NCT03443713
- Testing
- Dexcom G6 CGM
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Oregon Health and Science University
Diabetes, Glucose Variability
Develop Novel Methods to Display, Report and Analyze CGM Data for Clinical Decision-Making in People With Diabetes
The purpose of this study is to obtain sufficient continuous glucose monitoring (CGM) data in a manner that provides clinical information that is not available using conventional self-monitored blood glucose.
- Conditions
- Diabetes, Glucose Variability, CGM
- Trial name
- NCT00465881
- Testing
- CGM System for Type 1 and Type 2 Diabetes Mellitus
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- HealthPartners Institute
NonDiabetes, Glucose Variability
Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM Data
In a previous study we used the FreeStyle Navigator Continuous Glucose Monitoring (CGM) System to obtain 30 days of glucose measurements from 30 people with diabetes treated with insulin.
- Conditions
- NonDiabetes, Glucose Variability, CGM
- Trial name
- NCT00467675
- Testing
- CGM System for Type 1 and Type 2 Diabetes Mellitus
- Where
- United States
- Volunteers
- 35 people, healthy volunteers welcome
- Sponsor
- HealthPartners Institute